Potential therapeutic effects of baicalein, baicalin, and wogonin in ocular disorders

Journal of Ocular Pharmacology and Therapeutics

Volumn 30, Issue 8, 2014, Pages 605-614

  Xiao, Jing Ru ^a   Do, Chi Wai ^a   To, Chi Ho ^a,b  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 O ALKYLGLYCERO 3 PHOSPHORYLCHOLINE ACETYLTRANSFERASE; ALDEHYDE REDUCTASE; BAICALEIN; BAICALIN; ENZYME; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; REACTIVE OXYGEN METABOLITE; SCUTELLARIAE RADIX; UNCLASSIFIED DRUG; VASCULOTROPIN A; WOGONIN; FLAVANONE DERIVATIVE; FLAVONOID; HERBACEOUS AGENT;

AGE RELATED MACULAR DEGENERATION; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; DIABETIC RETINOPATHY; ENZYME INHIBITION; EYE DISEASE; HUMAN; NONHUMAN; RETINA CELL; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; REVIEW; SUBRETINAL NEOVASCULARIZATION; THERAPY EFFECT; UVEITIS; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; ENZYMOLOGY; EYE DISEASES; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; SCUTELLARIA BAICALENSIS;

ANIMALS; DRUGS, CHINESE HERBAL; EYE DISEASES; FLAVANONES; FLAVONOIDS; HUMANS; MOLECULAR STRUCTURE; SCUTELLARIA BAICALENSIS;

EID: 84911998352     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2014.0074     Document Type: Review

References (124)

1. Foster, A., Gilbert, C., and Johnson, G. Changing patterns in global blindness: 1988-2008. Community Eye Health 21:37-39, 2008.
2. World Health Organization. Visual impairment and blindness. 2013 www.who.int/mediacentre/factsheets/fs282/en/(accessed October 2013).
3. Chasan-Taber, L., Willett, W.C., Seddon, J.M., et al. A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women. Am. J. Clin. Nutr. 70:509-516, 1999.
4. Lyle, B.J., Mares-Periman, J.A., Klein, B.K., Klein, R., and Greger, J.L. Antioxidant intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. Am. J. Epidemiol. 149:801-809, 1999.
5. Moeller, S.M., Parekh, N., Tinker, L., et al. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative. Arch. Ophthalmol. 124:1151-1162, 2006.
6. Kimura, Y., Kubo, M., Tani, T., Arichi, S., Ohminami, H., and Okada, H. Studies on Scutellariae radix. IV. Effects on lipid peroxidation in rat liver. Chem. Pharm. Bull. 29:2610-2617, 1981.
7. Kubo, M., Matsuda, H., Tanaka, M., et al. Studies on Scutellariae radix. VII. Anti-arthritic and anti-inflammatory actions of methanolic extract and flavonoid components from Scutellariae radix. Chem. Pharm. Bul. 32: 2724-2729, 1984.
8. Lee, I.S., Park, S., Park, K., and Choue, R. Hepatopro-tective activity of Scutellariae radix Extract in mice fed ahigh fat diet with chronic alcohol exposure. Phytother. Res. 25:1348-1353, 2011.
9. Xin, H.G., Zhang, B.B., Wu, Z.Q., et al. Treatment with baicalein attenuates methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats. Eur. J. Pharmcol. 738:310-318, 2014.
10. Wang, Y.H., Yu, H.T., Pu, X.P., and Du, G.H. Baicalein prevents 6-hydroxydopamine-induced mitochondrial dysfunction in SH-SY5Y cells via inhibition of mitochondrial oxidation and up-regulation of DJ-1 protein expression. Molecules. 18:14726-14738, 2013.
11. Yu, C., Zhang, Z., Zhang, H., et al. Pretreatment of bai-calin and wogonoside with glycoside hydrolase: a promising approach to enhance anticancer potential. Oncol. Rep. 30:2411-2418, 2013.
12. Yeh, C.H., Shih, H.C., Hong, H.M., et al. Protective effect of wogonin on proinflammatory cytokine generation via Jak1/3-STAT1/3 pathway in lipopolysaccha-ride stimulated BV2 microglial cells. Toxicol. Indus. Health. 2013 [Epub ahead of print]; DOI: 10.1177/0748233713485886
13. Zheng, W.X., Wang, F., Cao, X.I., et al. Baicalin protects PC-12 cells from oxidative stress induced by hydrogen peroxide via anti-apoptotic effects. Brain Injury 28:227-234, 2014.
14. Zhang, S., Ye, J., and Dong, G. Neuroprotective effect of baicalein on hydrogen peroxide-mediated oxidative stress and mitochondrial dysfunction in PC12 cells. J. Mol. Neurosci. 40:311-320, 2010.
15. Wakabayashi, I. Inhibitory effects of baicalein and wogonin on lipopolysaccharide-induced nitric oxide production in macrophages. Pharmacol. Toxicol. 84:288-291, 1999.
16. Chen, Y.C., Shen, S.C., Chen, L.G., Lee, T.J., and Yang, L.L. Wogonin, baicalin and baicalein inhibition of in-ducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors, lipopolysaccharide. Biochem. Pharmacol. 61:1417-1427, 2001.
17. Chi, Y.S., Lim, H., Park, H., and Kim, H.P. Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochem. Pharmacol. 66:1271-1278, 2003.
18. Xu, J., Zhang, Y., Xiao, Y., et al. Inhibition of 12/15-lipoxygenase by baicalein induces microglia PPAR[beta]/[delta]: a potential therapeutic role for CNS autoimmune disease. Cell. Death Dis. 4:e569, 2013.
19. Mabalirajan, U., Ahmad, T., Rehman, R., et al. Baicalein reduces airway injury in allergen and IL-13 induced airway inflammation. PLoS One 8:e62916, 2013.
20. Wang, H.Z., Wang, H.H., Huang, S.S., et al. Inhibitory effect of baicalin on collagen-induced arthritis in rats through the nuclear factor-kB pathway. J. Ocul. Pharmacol. Ther. 350:435-443, 2014.
21. Hsieh, C.J., Hall, K., Ha, T., Li, C., Krishnaswamy, G., and Chi, D. Baicalein inhibits IL-1beta-and TNF-alpha-induced inflammatory cytokine production from human mast cells via regulation of the NF-kappaB pathway. Clin. Mol. Allergy 5:5, 2007.
22. Hou, J., Wang, J., Zhang, P., et al. Baicalin attenuates proinflammatory cytokine production in oxygen-glucose deprived challenged rat microglial cells by inhibiting TLR4 signaling pathway. Int. Immunopharmacol. 14:749-757, 2012.
23. Lombardo, E., Sabellico, C., Hájek, J., et al. Protection of cells against oxidative stress by nanomolar levels of hy-droxyflavones indicates a new type of intracellular anti-oxidant mechanism. PLoS One 8:e60796, 2013.
24. Gao, Z., Huang, K., Yang, X., and Xu, H. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochem. Biophys. Acta 1472:643-650, 1999.
25. Gao, D., Sakurai, K., Katoh, M., Chen, J., and Ogiso, T. Inhibition of microsomal lipid peroxidation by baicalein: a possible formation of an iron-baicalein complex. IUBMB Life 39:215-225, 1996.
26. Liu, B., Jian, Z., Li, Q., et al. Baicalein protects human melanocytes from H2O2-induced apoptosis via inhibiting mitochondria-dependent caspase activation and the p38 MAPK pathway. Free. Radic. Biol. Med. 53:183-193, 2012.
27. Moslehi, M., Meshkini, A., and Yazdanparast, R. Flavo-noid baicalein modulates H2O2-induced mitogen-activated protein kinases activation and cell death in SK-N-MC Cells. Cell. Mol. Neurobiol. 32:549-560, 2012.
28. Attia, S.M., Ahmad, S.F., Harisa, G.I., Mansour, A.M., El Sayed, E.S.M., and Bakheet, S.A. Wogonin attenuates etoposide-induced oxidative DNA damage and apoptosis via suppression of oxidative DNA stress and modulation of OGG1 expression. Food Chem. Toxicol. 59:724-730, 2013.
29. Liu, P.F., Han, F.G., Duan, B.B., Deng, T.S., Hou, X.L., and Zhao, M.Q. Purification and antioxidant activities of baicalin isolated from the root of huangqin (Scutellaria baicalensis gcorsi). J. Food. Sci. Technol. 50:615-619, 2013.
30. Shieh, D.E., Liu, L.T., and Lin, C.C. Antioxidant and free radical scavenging effects of baicalein, baicalin and wo-gonin. Anticancer Res. 20:2861-2865, 2000.
31. Perez, C.A., Wei, Y., and Guo, M. Iron-binding and anti-Fenton properties of baicalein and baicalin. J. Inorg. Biochem. 103:326-332, 2009.
32. Kim, K., Lee, I., Kang, K., Kim, H., Kang, S., and Hyun, J. Baicalein (5, 6, 7-trihydroxyflavone) reduces oxidative stress-induced DNA damage by upregulating the DNA repair system. Cell. Biol. Toxicol. 28:421-433, 2012.
33. Liu, J.J., Huang, T.S., Cheng, W.F., and Lu, F.J. Baicalein and baicalin are potent inhibitors of angiogenesis: inhibition of endothelial cell proliferation, migration and differentiation. Int. J. Cancer 106:559-565, 2003.
34. Lin, C.M., Chang, H., Chen, Y.H., Wu, I.S., and Chiu, J.H. Wogonin inhibits IL-6-induced angiogenesis via down-regulation of VEGF and VEGFR-1, but not VEGFR-2. Planta Med. 72:1305-1310, 2006.
35. Bai, K.J., Ma, H.P., Shyu, K.G., Ong, J.R., Chen, Y.H., and Lin, C.M. Functional role of wogonin in anti-angiogenesis. Am. J. Chin. Med. 40:415-427, 2012.
36. Spector, A., and Garner, W.H. Hydrogen peroxide and human cataract. Exp. Eye Res. 33:673-681, 1981.
37. Izzotti, A., Bagnis, A., and Sacca, S.C. The role of oxi-dative stress in glaucoma. Mutat. Res. 612:105-114, 2006.
38. Medzhitov, R. Origin and physiological roles of inflammation. Nature. 454:428-435, 2008.
39. Winkler, B.S., Boulton, M.E., Gottsch, J.D., and Stern-berg, P. Oxidative damage and age-related macular degeneration. Mol. Vis. 5:32, 1999.
40. Rattner, A., and Nathans, J. Macular degeneration: recent advances and therapeutic opportunities. Nat. Rev. Neu-rosci. 7:860-872, 2006.
41. Aiello, L.P., Avery, R.L., Arrigg, P.G., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331:1480-1487, 1994.
42. Kowluru, R.A. Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are interrelated. Acta. Diabetol. 38:179-185, 2001.
43. Robbins, S.L., Cotran, R.M., Kumar, V., Collins, T., and Schmitt, B. Acute and chronic inflammation. In: Robbin's Pathological Basis of Diseases, 6th ed. Philadelphia, PA: WB Saunders; 1999; pp. 50-88.
44. Hurst, J.S., and Bazan, H.E. The sensitivity of bovine corneal epithelial lyso-PAF acetyltransferase to cycloox-ygenase and lipoxygenase inhibitors is independent of arachidonate metabolites. J. Ocul. Pharmacol. Ther. 13: 415-426, 1997.
45. Chandrasekher, G., Ma, X., Lallier, T.E., and Bazan, H.E.P. Delay of corneal epithelial wound healing and induction of keratocyte apoptosis by platelet-activating factor. Invest. Ophthalmol.Vis. Sci. 43:1422-1428, 2002.
46. Gupta, A.G., Hirakata, A., and Proia, A.D. Effect of inhibitors of arachidonic acid metabolism on corneal re-epithelialization in the rat. Exp. Eye Res. 56:701-708, 1993.
47. Ohia, S.E., Opere, C.A., and Leday, A.M. Pharmacological consequences of oxidative stress in ocular tissues. Mutat. Res. 579:22-36, 2005.
48. Kyselova, Z., Stefek, M., and Bauer, V. Pharmacological prevention of diabetic cataract. J. Diabetes. Complications 18:129-140, 2004.
49. Head, K.A. Natural therapies for ocular disorders, part two: cataracts and glaucoma. Altern. Med. Rev. 6:141-166, 2001.
50. Kinoshita, J.H. Mechanisms initiating cataract formation. Proctor Lecture. Invest. Ophthalmol. Vis. Sci. 13:713, 1974.
51. Lee, A.Y., Chung, S.K., and Chung, S.S. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc. Natl. Acad. Sci. U. S. A. 92:2780-2784, 1995.
52. Varma, S.D., Schocket, S.S., and Richards, R.D. Implications of aldose reductase in cataracts in human diabetes. Invest. Ophthalmol. Vis. Sci. 18:237-241, 1979.
53. Beyer-Mears, A., and Cruz, E. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor. Diabetes. 34:15, 1985.
54. Li, S.Z., Mao, W.S., and Du, X.Y. Inhibition of rat lens aldose reductase by flavonoids-matteucinol and baicalein. Yan. Ke. Xue. Bao. 3:93-94, 137, 1987.
55. Park, C.H., Lim, S.S., and Lee, D.U. Structure-activity relationships of components from the roots of Pueraria thunbergiana having aldose reductase inhibitory and an-tioxidative Activity. Bull. Korean. Chem. Soc. 28:493-495, 2007.
56. Nagaki, Y., Hayasaka, S., Kadoi, C., Nakamura, N., and Hayasaka, Y. Effects of Scutellariae radix extract and its components (baicalein, baicalin, and wogonin) on the experimental elevation of aqueous flare in pigmented rabbits. Jpn. J. Ophthalmol. 45:216-220, 2001.
57. Nagaki, Y., Hayasaka, S., Zhang, X.Y., Hayasaka, Y., Nakamura, N., and Terasawa, K. Effects of topical instillation of traditional herbal medicines, herbal extracts, and their components on prostaglandin E2-induced aqueous flare elevation in pigmentedrabbits. Jpn. J. Ophthal-mol. 47:249-253, 2003.
58. Parks, D.J., Cheung, M.K., Chan, C.C., and Roberge, F.G. The role of nitric oxide in uveitis. Arch. Ophthalmol. 112:544-546, 1994.
59. Mandai, M., Mittag, T.W., Kogishi, J., Iwaki, M., Handai, M., and Yoshimura, N. Role of nitric oxide synthase isozymes in endotoxin-induced uveitis. Invest. Ophthal-mol. Vis. Sci. 37:826-832, 1996.
60. Bellot, J.L., Palmero, M., Alcoriza, N., et al. Concomitant treatment with a 5-lipoxygenase inhibitor improves the anti-inflammatory effect of the inhibition of nitric oxide synthase during the early phase of endotoxin-induced uveitis in rabbit. Ophthalmic. Res. 29:227-236, 1997.
61. Akira, S., Hirano, T., Taga, T., and Kishimoto, T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J. 4:2860-2867, 1990.
62. Murray, P.I., Hoekzema, R., Van Hare, M.A.C., De Hon, F.D., and Kijlstra, A. Aqueous humor interleukin-6 levels in uveitis. Invest. Ophthalmol. Vis. Sci. 31:917-920, 1990.
63. Hoekzema, R., Murray, P.I., Van Haren, M.A.C., Helle, M., and Kijlstra, A. Analysis of interleukin-6 in endotoxin-induced uveitis. Invest. Ophthalmol. Vis. Sci. 32:85-95, 1991.
64. Canataroglu, H., Varinli, I., Ozcan, A.A., Canataroglu, A., Doran, F., and Varinli, S. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreor-etinopathy. Ocul. Immunol. Inflamm. 13:375-381, 2005.
65. Verma, M., Lloyd, A., Rager, H., et al. Chemokines in acute anterior uveitis. Curr. Eye Res. 16:1202-1208, 1997.
66. Takai, Y., Tanito, M., and Ohira, A. Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma, and cataract. Invest. Ophthalmol. Vis. Sci. 53:241-247, 2012.
67. Kramer, M., Goldenberg-Cohen, N., Axer-Siegel, R., Weinberger, D., Cohen, Y., and Monselise, Y. Inflammatory reaction in acute retinal artery occlusion: cytokine levels in aqueous humor and serum. Ocul. Immunol. Inflamm. 13: 305-310, 2005.
68. Nakamura, N., Hayasaka, S., Zhang, X.Y., Nagaki, Y., Matsumoto, M., Hayasaka, Y., and Terasawa, K. Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-kb binding activities induced by interleukin-1b in human retinal pigment epithelial cell line. Exp. Eye Res. 77:195-202, 2003.
69. Lenardo, M.J., and Baltimore, D. NF-kB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58:227-229, 1989.
70. Grilli, M., Chiu, J.J.S., and Lenardo, M.J. NF-kB and rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1-62, 1993.
71. Klein, R., Klein, B.E., and Linton, K.L.P. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 99:933-943, 1992.
72. Vingerling, J.R., Dielemans, I., Hofmann, A., et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 102:205-210, 1995.
73. Hawkins, B.S., Bird, A., Klein, R., and West, S.K. Epidemiology of age-related macular degeneration. Mol. Vis. 5:26, 1999.
74. Beatty, S., Koh, H., Phil, M., Henson, D., and Boulton, M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 45:115-134, 2000.
75. Cai, J., Nelson, K.C., Wu, M., Sternberg Jr., P., and Jones, D.P. Oxidative damage and protection of the RPE. Prog. Retin. Eye Res. 19:205-221, 2000.
76. Miceli, M.V., Liles, M.R., and Newsome, D.A. Evaluation of oxidative processes in human retinal pigment epithelial cells associated with retinal outer segment phagocytosis. Exp. Cell. Res. 214:242-249, 1994.
77. Dorey, C.K., Khouri, G.G., Syniuta, L.A., Curran, S.A., and Weiter, J.J. Superoxide production by porcine retinal pigment epithelium in vitro. Invest. Ophthalmol. Vis. Sci. 30:1047-1054, 1989.
78. Mares-Perlman, J.A., Klein, R., Klein, B.E., et al. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch. Ophthalmol. 114:991-997, 1996.
79. AREDS Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch. Ophthalmol. 119:1417-1436, 2001.
80. Richer, S., Stiles, W., Statkute, L., et al. Double-masked, placebocontrolled, randomized trial of lutein and antiox-idant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry. 75:216-230, 2004.
81. Hanneken, A., Lin, F.F., Johnson, J., and Maher, P. Fla-vonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death. Invest. Ophthalmol. Vis. Sci. 47:3164-3177, 2006.
82. Liu, J.H., Wann, H., Chen, M.M., et al. Baicalein significantly protects human retinal pigment epithelium cells against H2O2-induced oxidative stress by scavenging reactive oxygen species and downregulating the expression of matrix metalloproteinase-9 and vascular endothelial growth factor. J. Ocul. Pharmacol. Ther. 26:421-429, 2010.
83. Tsai, D.C., Charng, M.J., Lee, F.L., Hsu, W.M., and Chen, S.J. Different plasma levels of vascular endothelial growth factor and nitric oxide between patients with choroidal and retinal neovascularization. Ophthalmologica. 220: 246-251, 2006.
84. Chau, K.Y., Sivaprasad, S., Patel, N., et al. Plasma levels of matrix metalloproteinase-2 and 9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye. 22:855-859, 2008.
85. Osborne, N.N., Li, G.Y., Ji, D., Mortiboys, H.J., and Jackson, S. Light affects mitochondria to cause apoptosis to cultured cells: possible relevance to ganglion cell death in certain optic neuropathies. J. Neurochem. 105:2013-2028, 2008.
86. Tezel, G. Oxidative stress in glaucomatous neurodegen-eration: mechanisms and consequences. Prog. Retin. Eye Res. 25:490-513, 2006.
87. Kowluru, R.A., Tang, J., and Kern, T.S. Abnormalities of retinal metabolism in diabetes and experimental galacto-semia.VII. Effect of long-term administration of antioxi-dants on the development of retinopathy. Diabetes. 50:1938-1942, 2001.
88. Maher, P., and Hanneken, A. Flavonoids protect retinal ganglion cells from oxidative stress-induced death. Invest. Ophthalmol. Vis. Sci. 46:4796-4803, 2005.
89. Jung, S.H., Kang, K.D., Ji, D., et al. The flavonoid baicalin counteracts ischemic and oxidative insults to retinal cells and lipid peroxidation to brain membranes. Neurochem. Int. 53:325-337, 2008.
90. Ishige, K., Schubert, D., and Sagara, Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free. Radic. Biol. Med. 30:433-446, 2001.
91. Osborne, N.N., Casson, R.J., Wood, J.P.M., Chidlow, G., Graham, M., and Melena, J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retin. Eye Res. 23:91-147, 2004.
92. Peng, P.H., Chao, H.M., Juan, S.H., Chen, C.F., Liu, J.H., and Ko, M.L. Pharmacological preconditioning by low dose cobalt protoporphyrin induces heme oxygenase-1 overexpression and alleviates retinal ischemia-reperfusion injury inrats. Curr. Eye Res. 36:238-246, 2011.
93. Chen, Y.Q., Pan, W.H.T., Liu, J.H., et al. The effects and underlying mechanisms of S-allyl L-cysteine treatment of the retina after ischemia/reperfusion. J. Ocul. Pharmacol. Ther. 28:110-117, 2012.
94. Maher, P., and Hanneken, A. Flavonoids protect retinal ganglion cells from ischemia in vitro. Exp. Eye Res. 86: 366-374, 2008.
95. Chao, H.M., C.M., Liu, J.H., et al. Baicalein protects against retinal ischemia by antioxidation, antiapoptosis, downregulation of HIF-1a, VEGF, and MMP-9 and up-regulation of HO-1. J. Ocul. Pharmacol. Ther. 29:539-549, 2013.
96. Ryter, S.W., Alam, J., and Choi, A.M. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 86:583-650, 2006.
97. Abraham, N.G., and Kappas, A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol. Rev. 60:79-127, 2008.
98. Sun, M.H., Pang, J.H., Chen, S.L., et al. Retinal protection from acute glaucoma-induced ischemia-reperfusion injury through pharmacologic induction of heme oxygenase-1. Invest. Ophthalmol. Vis. Sci. 51:4798-4808, 2010.
99. Liu, X.Q., Wu, B.J., Pan, W.H.T., et al. Resveratrol mitigates rat retinal ischemic injury: roles of matrix me-talloproteinase-9, inducible nitric oxide, and heme oxy-genase-1. J. Ocul. Pharmcol. Ther. 29:33-40, 2013.
100. Zarbin, M.A. Current concepts in the pathogenesis of age related macular degeneration. Arch. Ophthalmol. 122:598-614, 2004.
101. Hakansson, G., Gesslein, B., Gustafsson, L.L., et al. Hy-poxiainducible factor and vascular endothelial growth factor in the neuroretina and retinal blood vessels after retinal ischemia. J. Ocul. Biol. Dis. Inform. 3:20-29, 2010.
102. Guo, L., Moss, S.E., Alexander, R.A., et al. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest. Ophthalmol. Vis. Sci. 46:175-182, 2005.
103. Barber, A.J., Lieth, E., Khin, S.A., Antonetti, D.A., Buchanan, A.G., and Gardner, T.W. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J. Clin. Invest. 102:783-791, 1998.
104. Elner, S.G., Elner, V.M., Jaffe, G.J., Stuart, A., Kunkel, S.L., and Strieter, R.M. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr. Eye Res. 14:1045-1053, 1995.
105. Abu El-Asrar, A.M., Desmet, S., Meersschaert, A., Dra-lands, L., Missotten, L., and Geboes, K. Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am. J. Ophthalmol. 132:551-556, 2001.
106. Krady, J.K., Basu, A., Allen, C.M., et al. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes. 54:1559-1565, 2005.
107. Yang, L.P., Sun, H.L., Wu, L.M., et al. Baicalein re-ducesinflammatory process in a rodent model of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 50:2319-2327, 2009.
108. Othman, A., Ahmad, S., Megyerdi, S., et al. 12/15-Lipoxygenase-derived lipid metabolites induce retinal endothelial cell barrier dysfunction: contribution of NADPH oxidase. PLoS One. 8:e57254, 2013.
109. Erickson, K.K., Sundstrom, J.M., and Antonetti, D.A. Vascular permeability in ocular disease and the role of tight junctions. Angiogenesis 10:103-117, 2007.
110. Zhang, K., Zhang, L., and Weinreb, R.N. Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma. Nat. Rev. Drug. Discov. 11:541-559, 2012.
111. Lee, P., Wang, C.C., and Adamis, A.P. Ocular neo-vascularization: an epidemiologic review. Surv. Ophthal-mol. 43:245-269, 1998.
112. Fine, S.L., Berger, J.W., Maguire, M.G., and Ho, A.C. Age-related macular degeneration. N. Engl. J. Med. 342:483-492, 2000.
113. Tian, H., et al. Federation of American Societies for Experimental Biology. FASEB J. 23:Meeting Abstract Supplement 592.25, 2009.
114. Brown, D.M., Kaiser, P.K., Michels, M., et al. Ranibizu-mab versus verteporfin for neovascular age-related mac-ular degeneration. N. Engl. J. Med. 355:1432-1444, 2006.
115. Amin, R., Puklin, J.E., and Frank, R.N. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 35:3178-3188, 1994.
116. Higgins, G.T., Wang, J.H., Dockery, P., Cleary, P.E, and Redmond, H.P. Induction of angiogenic cytokine expression in cultured RPE by ingestion of oxidized photoreceptor outer segments. Invest. Ophthalmol. Vis. Sci. 44:1775-1782, 2003.
117. Hageman, G.S., Luthert, P.J., Victor Chong, N.H., Johnson, L.V., Anderson, D.H., and Mullins, R.F. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res. 20:705-732, 2001.
118. Yang, S.J., Jo, H., Kim, J.G., and Jung, S.H. Baicalin attenuates laser-induced choroidal neovascularization. Curr. Eye Res. 39:745-751, 2014.
119. Bussolino, F., Mantovani, A., and Persico, G. Molecular mechanisms of blood vessel formation. Trends. Biochem. Sci. 22:251-256, 1997.
120. Aiello, L.P., Pierce, E.A., Foley, E.D., et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. U. S. A. 92:10457-10461, 1995.
121. Adamis, A.P., Miller, J., Bernal, M.T., et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Oph-thalmol. 118:445-450, 1994.
122. Miller, J.W., Adamis, A.P., and Aiello, L.P. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. Diabetes Metab. Rev. 13:37-50, 1997.
123. Dawson, D.W., Volpert, O.V., Gillis, P., et al. Pigment epithelium-derived factor: a potent inhibitor of angio-genesis. Science. 285:245-248, 1999.
124. Al-Shabrawey, M., Mussell, R., Kahook, K., et al. Increased expression and activity of 12-lipoxygenase in oxygen-induced ischemic retinopathy and proliferative diabetic retinopathy: implications in retinal neovascular-ization. Diabetes. 60:614-624, 2011.